The generic medicine was also withdrawn in Saudi Arabia for failing to comply with the branded product
Dubai: The Ministry of Health and Prevention issued a circular on Monday withdrawing a diabetic medicine from the UAE market.
The Dialon 500mg tablets contained the active ingredient metformin, which was manufactured by the pharmaceutical company Julphar.
The circular stated that the generic medicine was withdrawn after a recent report compared it to the branded product.
According to the circular, the ministry also received another health and safety report from the Saudi Food and Drug Administration indicating the failure of the product.
Diabetes is a chronic disease with the potential of affecting all organs and organ systems. About 15 per cent of Dubai’s population are diabetic. Gulf News archives
Dr Amin Hussain Al Amiri, Assistant Under-Secretary for Public Health Policy and Licensing at the ministry, said the circular to withdraw the medicine was issued to directors of medical zones, government and private hospital directors, doctors, pharmacists and pharmacy assistants to the directors of state and private pharmacies.
Al Amiri said that the Ministry of Health and Prevention is in daily contact with local pharmaceutical factories, the US Food and Drug Administration, the European and Australian Medicines.
“If any warning is issued, a circular is immediately issued to all health authorities to remove these drugs and destroy them,” Al Amiri was quoted by the state news agency WAM.
He appealed to members of the society not to circulate or use the product, urging the public to report any side effects by contacting the ministry on 04-3201448 or by e-mail at firstname.lastname@example.org.